July 22, 2009

High Off-Label Use Of Antipsychotics For Depression In VA System

A new study in the Journal of Clinical Psychiatry identifies that many thousands of veterans in the VA system are being given antipsychotics for the treatment of depression, a finding that is startling and unsettling. CL Psych had some thoughts on all of this the other day.

From the study:

"RESULTS: Altogether, 20.6% of veterans with MDD received antipsychotic medications, and 43% of those who did received them at the higher doses recommended for schizophrenia. GEE models showed that younger age, male gender, psychiatric comorbidities, duration of diagnosed MDD, and more intensive mental health service use were all associated with greater likelihood of receiving antipsychotics and with less likelihood of receiving them at conventional antipsychotic doses.

"CONCLUSION: Antipsychotic medications were commonly used in the treatment of MDD prior to FDA approval, especially in the presence of comorbid mental illness and longer term MDD. Further research is needed to evaluate the long-term safety and efficacy of these medications in combination with antidepressants."

Keep in mind this study covered people in the VA system in 2007 and the most widely used antipsychotic for depression within the VA system was Seroquel. But Seroquel isn't approved for treating depression (it is approved for bipolar depression), so this is a very high level of off-label use by the VA and sure makes me curious if there's been any off-label marketing going on by AstraZeneca, which was dinged by the FDA last December for off-label marketing of Seroquel for depression, or what circumstances led the VA to adopt Seroquel and other antipsychotics for use in depression when the available evidence suggests that these drugs are neither particularly safe or efficacious in treating depression.

In other words, I smell a rat.

Posted by Philip Dawdy at July 22, 2009 12:03 AM
StumbleUpon Toolbar del.icio.us Digg it reddit
Comments

One of my main Google searches that gets to my blog is "seroquel withdrawals" and interesting, that in the last 2 years the stat meter consistently shows the navy and pentagon doing those google searches.

Posted by: Stephany at July 22, 2009 12:09 AM

I agree. I smell a rat. VA is the world's largest integrated health care system ever, anywhere. They have, and use, the opportunity to achieve great cost savings through restricting prescribing practices - controlling the range of drugs they buy, etc. They have in the past - I don't know about current practice - encouraged the prescription of pills at double the dose needed, and provided pill-cutters to vets, so that the VA can save money by having a vet take half a pill each day in the cases where this saves money.

So, it is surprising to see such off-label prescribing. But who knows who is schmoozing whom. The VAs generally do allow drug reps. A former director of the dallas VA had banned reps, but that was an uncommon policy for a VA hospital.

Posted by: medsvstherapy at July 22, 2009 06:22 AM

The phrase I routinely hear from the two Seroquel reps when they visit my office is: "If you see residual untreated depressive symptoms, we want you to think about Seroquel."

Of course, they'll say they're talking about symptoms of bipolar depression (for which Seroquel is, ahem, "approved") but this wording clearly indicates they're trying to get doctors to make the depression = Seroquel connection. Shady? Yes. Illegal? Unfortunately, no.

Posted by: SteveBMD at July 22, 2009 07:33 AM

The VA will have a lot to answer for when the death rate increases among soldiers just as the suicide rate has increased among soldiers because of the blatantly high use of antidepressants given to them.

As co-founder of www.SSRIstories.com I was very interested in the new atypical antipsychotics since they are half antidepressant.

Although I did not have the time to search everyday for news stories about violence & suicide with all the atypicals, I have been doing some research for several years on the types of diseases the atypicals cause to the individuals taking them. Of course, everyone knows now about the diabetes and metabolic syndrome disorders caused by the atypicals.

Probably less well known is the stats pointing to a possible increase in cancer deaths among the users of atypicals.

I had to study the atypicals via the disease model of "schizophrenia" [usage of atypical antipsychotics] since they were the studies that were most accessible and most reported on by epidemiologists. This first Website shows that in 1986 people with schizophrenia had a lesser chance [adjusted for age] of developing cancer. They were at .59

http://www.ncbi.nlm.nih.gov/pubmed/12223244

This second Website shows that by 1999 [seven years after the introduction of the atypicals], the cancer rate for schizophrenics was at .99 -- in other words-- about equal to the general population.

http://bjp.rcpsych.org/cgi/content/abstract/187/4/334

This third Website shows that by 2003 the cancer rate was 1.5 for those diagnosed as schizophrenia

http://www.oncolink.com/resources/article.cfm?c=3&s=8&ss=23&id=16312&month=06&year=2009

This article from the New York Times, written in 1992 right before the introduction of the atypicals, is interesting in that it may point to a possible explanation for the decrease in cancer among schizophrenics.

http://query.nytimes.com/gst/fullpage.html?res=980DE2D61638F932A0575BC0A962958260&sec=health&pagewanted=print

Also, this Website reports on the sudden cardiac deaths for those on typical and atypical antipsychoitcs. The chart shows: typical low dose is 1.30, typical moderate dose is 2.01 and higher doses are 2.42

For the atypical antipsychotics, this chart shows that a low dose was 1.59, a moderate dose of an atypical was 2.13 and a higher dose was 2.86.

http://pn.psychiatryonline.org/cgi/content/full/44/5/1

God bless the soldiers.

Posted by: Rosie at July 22, 2009 01:04 PM

My hunch (not as an expert on veterans, but as a mom, and as someone who has worked with institutionalized children in youth, and with special ed kids as a volunteer now) is that the reason atypicals are being prescribed for depression is not to treat the depression itself, but to tone down some of the possible manifestations of depression in young males: namely, irritability, possible aggression and violence directed at oneself (suicide attempts) or family members. Forgive my painting with a broad brush, but at least some depressed men act angry rather than sad, and this is very threatening to many people. In addition, calling someone's difficulties "depression" is less stigmatizing than labelling them with a bipolar or a personality disorder diagnosis (atypicals are frequently prescribed for the latter).

I have read that in prisons, violent prisoners are sometimes prescribed lithium and other mood stabilizers, not always to treat unequivocally diagnosed bipolar disorder, but to minimize aggression. At least, that is the rationale.

Societies generally prefer tranquillizing people they cannot immediately heal. Hence the vast numbers of prescriptions currently written for atypicals for children (mostly boys) with conditions like autism, possible bipolar, and various conduct disorders.

It's appalling. But with such inadequate meds and not enough clinicians and people unable to afford care, even when available, such stop gap measures are inevitable.

Posted by: retriever at July 22, 2009 04:20 PM
Post a comment









Remember personal info?






pic1.jpg

Winter Fundraiser Underway!!!
Patient Blogs. Sites.
Doctor Blogs. Sites.
Activists. News.
Social Networking. Forums.
Science. Big Pharma. Ethics.
Current Affairs
Seattle Stuff
Smoking. Stuff.

Info
About Furious Seasons
Email
Other Articles
ZYPREXA Documents
Alt ZYPREXA Documents Source
Blakemore-Brown Transcript

 Subscribe in a reader

Recent Entries
Winter Fundraiser, An Early Start
Reasons To Be Skeptical Of "Female Viagra" Drug, Big Pharma's Spanish Fly
Medical Marijuana For Autism?
AstraZeneca Whines About Chicago Tribune's Seroquel Coverage
Big Pharma's Sneaky Trick
Researchers Ignore Problems With Meds In Early Deaths, Blame Smoking, No Exercise
Researchers' New Pediatric Bipolar Disorder Symptoms Include Bed Wetting, Nightmares
Fort Hood Shooting: Was Psychiatrist-Shooter Psychotic Or A Terrorist?
Yale Researcher Links Childhood ADHD To Adult Crime, Drug Dealing
Senator Wants Pentagon To Account For Troop Anti-Depressant Use, Suicide Link
British Government To Limit Antipsychotic Use For Dementia
Child Psychiatrists Behaving Badly With Children
Utah Settles Zyprexa Claims For $24 Million
Psychiatrist Got $490,000 Pimping For Seroquel, Engaged In Wide Off-Label Use
Why Auto Insurance And Health Insurance Aren't The Same, Mr. President
Recent Comments

retriever on High Off-Label Use Of Antipsychotics For Depression In VA System

Rosie on High Off-Label Use Of Antipsychotics For Depression In VA System

SteveBMD on High Off-Label Use Of Antipsychotics For Depression In VA System

medsvstherapy on High Off-Label Use Of Antipsychotics For Depression In VA System

Stephany on High Off-Label Use Of Antipsychotics For Depression In VA System

Archives
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
March 2006
February 2006
January 2006
December 2005
November 2005
October 2005
September 2005
Resources
Mental Health America
National Alliance on Mental Illness
Depression and Bipolar Support Alliance
National Institute of Mental Health
McMan Web
Search


Powered by
Movable Type 3.2